Sarah Cannon Research Institute at HealthOne — Denver, Colorado

Sarah Cannon Research Institute at HealthOne is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at HealthOne has participated in 14 clinical trials with 6 currently active.

Therapeutic areas: Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon.

Sponsors: SCRI Development Innovations, LLC, Sumitomo Pharma America, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at HealthOne?

Sarah Cannon Research Institute at HealthOne has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at HealthOne conducted?

Sarah Cannon Research Institute at HealthOne has 14 clinical trials on record, with 6 currently active. Their work covers Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon.

Is Sarah Cannon Research Institute at HealthOne accredited by Crixeo Health?

Yes — Sarah Cannon Research Institute at HealthOne holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Research Institute at HealthOne?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.